2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Radioimmunodetection: new trials by email Literature Review of Radioimmunodetection trials Research Report on Radioimmunodetection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma immunoscintigraphy, technetium Tc 99m epratuzumab - Lymphoma | Phase 2 / Phase 3 | Unknown | Gilead Sciences | 60 | 1997-03-01 | 2021-08-16 |
| Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma immunoscintigraphy, technetium Tc 99m epratuzumab - Lymphoma | Phase 3 | Unknown | Gilead Sciences | 100 | 1997-03-01 | 2021-08-16 |
Burkitt Lymphoma (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Large-Cell, Immunoblastic (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, Non-Hodgkin (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)
Gilead Sciences (2)
Austria (2) · Italy (2) · Sweden (2) · Switzerland (2) · United States (2)